Drug | Tablet
Gliclazide modified release 30 mg
Type 2 diabetes mellitus in adults requiring improved glycemic control along with diet and exercise.
Gliclazide MR stimulates insulin release from pancreatic beta cells and improves glucose utilization. The modified-release formulation provides more even drug release to help maintain blood sugar control through the day.
Take once daily with breakfast, swallow whole (do not crush/chew). Maintain regular meals and monitor glucose; dose is titrated by doctor based on response.
Common side effects of Diamicron MR 30 Tablet may include:
Hypoglycemia risk increases with missed meals, alcohol, or intense exercise. Use caution in elderly and in renal/hepatic impairment; not for type 1 diabetes or diabetic ketoacidosis. Inform doctor about fasting, surgery, or acute illness.
